NEWS

Leading Brand For Chinese Beverage

Position - News

GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Accelerates its Internationalization by Leveraging the World Economic Forum

2018-09-10 1930 browsing



Chairman of GPHL LI Chuyuan, as the sole representative of domestic pharmaceutical companies, attended the World Economic Forum held in Switzerland along with the delegation group led by REN Xuefeng, Secretary of Guangzhou Municipal Party Committee, and has talked with many global giants such as Alibaba Group and Siemens.       


 GPHL Net News (Text by PEI Ran, LI Yuewen) January 18 to 24, 2015, LI Chuyuan, Chairman of GPHL, as the sole representative of domestic pharmaceutical companies, attended the World Economic Forum held in Switzerland along with the delegation group led by REN Xuefeng, Secretary of Guangzhou Municipal Party Committee, and dropped by France and Germany. GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited had successively talked with several global giants including Alibaba Group, Siemens, Philips, General Motors, Nestle, Sanofi, Microsoft, BCG, Systema (Russia), etc., and reached consensus on multiple projects. Chairman LI Chuyuan indicated that World Economic Forum brought GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited many new concepts and new thoughts, and by leveraging the platform of World Economic Forum, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited will accelerate its nationalization; meanwhile, it would take medical devices and diagnostic reagents as the key sector to be built.


 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is the sole pharmaceutical enterprise that was invited to attend the Forum.


 It is reported that this session of World Economic Forum has gathered top politicians and enterprises from all over the world, including a dozen companies from China, among which include GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, the sole pharmaceutical enterprise that is invited to attend the Forum. This is also the first time for GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited to attend the World Economic Forum. During the Forum, Guangzhou delegation led by Secretary REN Xuefeng paid a visit to Prof. Schwab, Chairman of the World Economic Forum, and Chairman LI Chuyuan and other representatives of the delegation received warm reception from President Schwab.

       

 Thanks to its status in Chinese pharmaceutical industry, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was invited to attend the Forum. It is reported that GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, as the biggest pharmaceutical group in China and owning several famous brands such as Wanglaoji, etc., has continued to hold the champion in China’s Top 100 Pharmaceutical Enterprises issued by National Ministry of Industry and Information Technology for many years, and has established joint venture companies with world's largest pharmaceutical business giants including Walgreens Boots Alliance, Hutchison Whampoa and Baxter International Inc., etc. In terms of internationalization, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has already started the layout internationally; and in terms of product export, Wanglaoji has covered the markets of over 50 countries and regions throughout the world, and Huatuo Zaizao Pill has been steadily ranked No. 1 in export volume for many years. After many years' development, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's international influence and brand awareness have been greatly improved.

      

 LI Chuyuan expressed that it's the second time for GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited to appear at an international stage followed its attendance of APCE last year. It's not only a good opportunity for it to give ear to the voice of the world, but also an opportunity for it to make the world know about Guangzhou, and GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited as well. The Forum has brought GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited many new strategies and new thoughts.


Accelerating Overall Internationalization through the Layout in Medical Devices and Diagnostic Reagents

       

During this session of World Economic Forum, LI Chuyuan met with several global giants such as Siemens, Philips, Sanofi, General Motors, Walgreens Boots Alliance, and Microsoft, Nestle and BCG, etc. As the global giants in medical devices and diagnostic reagents, the joint market share of Siemens, Philips, and General Motors accounts for 70% of China's high-end medical device market.

    

 LI Chuyuan said that the market prospect for medical devices and diagnostic reagents is very good. The annual growth rate in average in China can exceed 25%, which is higher than that of pharmaceutical industry. However in China, medical device sector only account for about 13% of total sales revenue of pharmaceutical industry in contrast with about 50% in Europe and the United States, which means that China has huge market potential. At present, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is in the process of conducting new industrial layout adjustment, and in addition to its three existing key sectors, i.e. Great Southern Medicine, Big Health and Big Business, it will cultivate and build medical devices and diagnostic reagents as another key sector. Through the introduction and resources and talents, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited will cut in the sector by conducting international cooperation, M&A, and equity participation and aiming at internationalization at the start-up stage of industrial layout.

    

 During the World Economic Forum, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited made a special visit to University of Hannover's high-end medical device invention expert(s), and then went to the Siemens Headquarters to conduct investigation and survey along with the delegation group led by Secretary REN Xuefeng and reached multiple consensus with Siemens on Medical Care and Industry 4.0. These two sides will cooperate in a number of IVD Reagent products, involving HIV, hepatitis A, hepatitis B, hepatitis C and other diseases, which opened a good start for GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's expansion to new business and further internationalization.

  

 Before the Forum, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited had communicated and studied with industrial giants nationwide and government agencies about holding a symposium on medical device and diagnostic reagent strategy. This October, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited also communicated and exchanged ideas with Dr. Smoot, the winner of 2006 Nobel Prize in Physics, and as a result, both sides will work together in such fields as medical devices and wearable devices, etc.


 Achieved multiple consensus with MA Yun

       

  On January 13 this year, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited raised RMB10 billion of funds, and among all investors, MA Yun's Yunfeng Fund became the only strategic investor. At the same time, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited had also reached a strategic cooperation intention with MA Yun's Ali Health.

 


 During this session of World Economic Forum, GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited and MA Yun that both were invited to attend the Forum had met four times in only three days. It is reported that the cooperation between these two sides has received strong support from Secretary REN Xuefeng, and both parties have reached multiple consensuses. GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited will carry out comprehensive strategic cooperation with Alibaba Group. Meanwhile, these two sides will also promote more cooperation in the aspects of medical health services, etc., and the form of cooperation has the potential of establishing joint ventures.Consumables have always been the focus of Yunfeng Fund's investment. This time, Yunfeng Fund's buying into of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is also because it is optimistic about Wanglaoji's future development. According to the information, among the talks between GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited and MA Yun, Wanglaoji also became a focus. There's potential for two sides to cooperate in campus football and other aspects, so as to jointly promote WanglLaoji's brand influence.
      

 LI Chuyuan said that this session of World Economic Forum has given the opportunity for GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited to have a close contact with world's top politicians and business giants, and also brought many opportunities for cooperative development to GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited will make full use of the resources collected from the Forum, and take the opportunity as a new starting point for international development, to promote the great-leap-forward development of GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited.



GPHL Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited and MA Yun that both were invited to attend the Forum, had met four times in only three days and reached a consensus to conduct overall strategic cooperation, meanwhile, both sides will promote more cooperation in such aspects as medical treatment and health, etc.



Chairman LI Chuyuan and Wanglaoji boarded the World Economic Forum Together